Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Candace Andersson |
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
Emerging roles for novel antipsychotic medications in the treatment of schizophrenia / Candace Andersson en Psychiatric Clinics of North America, Año 1998- Vol. 21 No. 1 (Marzo)
[artículo]
Título : Emerging roles for novel antipsychotic medications in the treatment of schizophrenia Tipo de documento: texto impreso Autores: Candace Andersson, Autor ; Miranda Chakos, Autor ; Richard Mailman, Autor Fecha de publicación: 2020 Artículo en la página: pp. 151-179 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Benzodiazepinas, Pirenzepina, Psicofarmacología, Esquizofrenia, Discinesia inducida por fármacos. Resumen: Antipsychotic medications are the mainstay of treatment for schizophrenia. The recent advent of atypical antipsychotics has provided new clinical options and set higher expectations for the treatment of schizophrenia. It is not yet clear how each different drug will fit within the therapeutic armamentarium and this lack is most evident with considering patients with treatment refractory schizophrenia. Link: ./index.php?lvl=notice_display&id=25073
in Psychiatric Clinics of North America > Año 1998- Vol. 21 No. 1 (Marzo) . - pp. 151-179[artículo] Emerging roles for novel antipsychotic medications in the treatment of schizophrenia [texto impreso] / Candace Andersson, Autor ; Miranda Chakos, Autor ; Richard Mailman, Autor . - 2020 . - pp. 151-179.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Psychiatric Clinics of North America > Año 1998- Vol. 21 No. 1 (Marzo) . - pp. 151-179
Palabras clave: Benzodiazepinas, Pirenzepina, Psicofarmacología, Esquizofrenia, Discinesia inducida por fármacos. Resumen: Antipsychotic medications are the mainstay of treatment for schizophrenia. The recent advent of atypical antipsychotics has provided new clinical options and set higher expectations for the treatment of schizophrenia. It is not yet clear how each different drug will fit within the therapeutic armamentarium and this lack is most evident with considering patients with treatment refractory schizophrenia. Link: ./index.php?lvl=notice_display&id=25073